title: Therapeutic effects of pharmacologically induced hypothermia against traumatic brain injury in mice.
abstract: Preclinical and clinical studies have shown therapeutic potential of mild-to-moderate hypothermia for treatments of stroke and traumatic brain injury (TBI). Physical cooling in humans, however, is usually slow, cumbersome, and necessitates sedation that prevents early application in clinical settings and causes several side effects. Our recent study showed that pharmacologically induced hypothermia (PIH) using a novel neurotensin receptor 1 (NTR1) agonist, HPI-201 (also known as ABS-201), is efficient and effective in inducing therapeutic hypothermia and protecting the brain from ischemic and hemorrhagic stroke in mice. The present investigation tested another second-generation NTR1 agonist, HPI-363, for its hypothermic and protective effect against TBI. Adult male mice were subjected to controlled cortical impact (CCI) (velocity=3 m/sec, depth=1.0 mm, contact time=150 msec) to the exposed cortex. Intraperitoneal administration of HPI-363 (0.3 mg/kg) reduced body temperature by 3-5°C within 30-60 min without triggering a shivering defensive reaction. An additional two injections sustained the hypothermic effect in conscious mice for up to 6 h. This PIH treatment was initiated 15, 60, or 120 min after the onset of TBI, and significantly reduced the contusion volume measured 3 days after TBI. HPI-363 attenuated caspase-3 activation, Bax expression, and TUNEL-positive cells in the pericontusion region. In blood-brain barrier assessments, HPI-363 ameliorated extravasation of Evans blue dye and immunoglobulin G, attenuated the MMP-9 expression, and decreased the number of microglia cells in the post-TBI brain. HPI-363 decreased the mRNA expression of tumor necrosis factor-α and interleukin-1β (IL-1β), but increased IL-6 and IL-10 levels. Compared with TBI control mice, HPI-363 treatments improved sensorimotor functional recovery after TBI. These findings suggest that the second generation NTR-1 agonists, such as HPI-363, are efficient hypothermic-inducing compounds that have a strong potential in the management of TBI.
authors.affiliation: 1 Department of Anesthesiology, Emory University School of Medicine , Atlanta, Georgia .
authors.forename: Jin Hwan
authors.initials: JH
authors.lastname: Lee
authors.forename: Ling
authors.initials: L
authors.lastname: Wei
authors.forename: Xiaohuan
authors.initials: X
authors.lastname: Gu
authors.forename: Zheng
authors.initials: Z
authors.lastname: Wei
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Dix
authors.forename: Shan Ping
authors.initials: SP
authors.lastname: Yu
mesh_terms: D000818:Animals; D015153:Blotting, Western; D001930:Brain Injuries / Q000473:pathology*; D004195:Disease Models, Animal; D007036:Hypothermia, Induced / Q000379:methods*; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009842:Oligopeptides / Q000494:pharmacology*; D060888:Real-Time Polymerase Chain Reaction; D018028:Receptors, Neurotensin / Q000819:agonists*
chemical_list: C000597347:HPI-363; D009842:Oligopeptides; D018028:Receptors, Neurotensin; C114036:neurotensin type 1 receptor
keywords: blood–brain barrier; hypothermia; inflammation; neurotensin analogue; sensorimotor function; traumatic brain injury
references.citation: Pediatr Crit Care Med. 2010 Jan;11(1):109-16
references.pmid: 19602992
references.citation: Stroke. 2000 Sep;31(9):2251-6
references.pmid: 10978060
references.citation: Sci Transl Med. 2010 Apr 14;2(27):27rv1
references.pmid: 20393189
references.citation: J Neurosurg. 2000 Oct;93(4):546-9
references.pmid: 11014530
references.citation: Neurosurgery. 2004 Mar;54(3):713-7; discussion 717-8
references.pmid: 15028148
references.citation: Cell Mol Neurobiol. 2000 Feb;20(1):57-76
references.pmid: 10690502
references.citation: Brain Res Mol Brain Res. 2005 Aug 18;138(2):124-34
references.pmid: 15922484
references.citation: PLoS One. 2013 Jul 23;8(7):e68877
references.pmid: 23894362
references.citation: Prog Neurobiol. 2005 Feb;75(3):207-46
references.pmid: 15882775
references.citation: J Neurotrauma. 1994 Jun;11(3):289-301
references.pmid: 7996583
references.citation: J Cereb Blood Flow Metab. 1992 Sep;12(5):817-22
references.pmid: 1506446
references.citation: Neuropharmacology. 2005 Mar;48(3):417-25
references.pmid: 15721174
references.citation: J Neurosci. 1999 Jan 1;19(1):503-10
references.pmid: 9870978
references.citation: Stroke. 1998 Oct;29(10):2171-80
references.pmid: 9756600
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1983-8
references.pmid: 17261803
references.citation: Front Biosci. 2007 Jan 01;12:816-25
references.pmid: 17127332
references.citation: J Neurosci Methods. 2007 Mar 15;160(2):187-96
references.pmid: 17049995
references.citation: Trends Neurosci. 1992 Jan;15(1):9-13
references.pmid: 1374957
references.citation: J Cereb Blood Flow Metab. 2002 Oct;22(10):1231-8
references.pmid: 12368662
references.citation: J Neurotrauma. 2009 Jul;26(7):1123-34
references.pmid: 19558276
references.citation: EMBO Rep. 2005 Jul;6 Spec No:S39-44
references.pmid: 15995660
references.citation: J Cereb Blood Flow Metab. 2012 Oct;32(10):1939-47
references.pmid: 22781337
references.citation: Exp Neurol. 2013 Jan;239:183-91
references.pmid: 23059456
references.citation: J Cereb Blood Flow Metab. 2008 Apr;28(4):674-83
references.pmid: 18059433
references.citation: J Biol Chem. 1975 Mar 10;250(5):1912-8
references.pmid: 1112838
references.citation: Acad Emerg Med. 1997 Jan;4(1):33-9
references.pmid: 9110009
references.citation: Neurocrit Care. 2008;8(1):42-7
references.pmid: 17922082
references.citation: NeuroRehabilitation. 2007;22(5):341-53
references.pmid: 18162698
references.citation: J Neuroimmunol. 1997 Feb;72(2):169-77
references.pmid: 9042110
references.citation: Intensive Care Med. 2004 Apr;30(4):556-75
references.pmid: 14767591
references.citation: J Cereb Blood Flow Metab. 2010 Jun;30(6):1079-93
references.pmid: 20354545
references.citation: FASEB J. 2012 Jul;26(7):2799-810
references.pmid: 22459147
references.citation: Surgery. 2008 Nov;144(5):803-13
references.pmid: 19081024
references.citation: Trends Pharmacol Sci. 2010 Dec;31(12):596-604
references.pmid: 21035878
references.citation: J Appl Physiol (1985). 2006 Apr;100(4):1400-9
references.pmid: 16239608
references.citation: Am J Prev Med. 2008 Apr;34(4 Suppl):S112-5
references.pmid: 18374259
references.citation: Neuroscience. 2004;129(4):1021-9
references.pmid: 15561417
references.citation: Brain Res Mol Brain Res. 2003 Jan 31;110(1):63-75
references.pmid: 12573534
references.citation: MMWR Surveill Summ. 2011 May 6;60(5):1-32
references.pmid: 21544045
references.citation: J Clin Psychiatry. 1996 Dec;57(12):582-7
references.pmid: 9010122
references.citation: Nat Rev Neurol. 2010 Jul;6(7):393-403
references.pmid: 20551947
references.citation: J Crit Care. 2011 Jun;26(3):311-5
references.pmid: 20889287
references.citation: J Neurotrauma. 2000 Oct;17(10):927-38
references.pmid: 11063058
references.citation: Medscape J Med. 2008;10(9):212
references.pmid: 19008974
references.citation: Acta Neuropathol. 2008 Jun;115(6):635-42
references.pmid: 18357461
references.citation: J Neurotrauma. 1994 Oct;11(5):499-506
references.pmid: 7861443
references.citation: J Trauma. 2002 Dec;53(6):1152-9
references.pmid: 12478043
references.citation: J Med Chem. 2009 Apr 9;52(7):1803-13
references.pmid: 19290594
references.citation: J Cereb Blood Flow Metab. 2003 May;23(5):513-30
references.pmid: 12771566
references.citation: Mediators Inflamm. 2012;2012:762840
references.pmid: 22481864
references.citation: J Neurosurg. 2012 Oct;117(4):714-20
references.pmid: 22839656
references.citation: Exp Neurol. 1999 Aug;158(2):444-50
references.pmid: 10415151
references.citation: Surg Neurol. 2003 May;59(5):381-5
references.pmid: 12765810
references.citation: J Neurotrauma. 2012 Nov 20;29(17):2660-71
references.pmid: 22985250
references.citation: Shock. 2001 Sep;16(3):165-77
references.pmid: 11531017
references.citation: J Neurosurg. 1998 Oct;89(4):507-18
references.pmid: 9761042
references.citation: Exp Mol Med. 2011 Feb 28;43(2):121-8
references.pmid: 21278483
references.citation: Brain Res. 2002 May 24;937(1-2):22-31
references.pmid: 12020858
references.citation: Anesthesiology. 2000 May;92(5):1343-9
references.pmid: 10781280
references.citation: Acta Neurochir Suppl. 1998;71:131-4
references.pmid: 9779165
references.citation: Intensive Care Med. 2002 Nov;28(11):1563-73
references.pmid: 12415442
references.citation: Neurosurgery. 2005 Apr;56(4):740-54; discussion 740-54
references.pmid: 15792513
references.citation: Stroke. 2001 Sep;32(9):2033-5
references.pmid: 11546893
references.citation: Neuropharmacology. 2005 Dec;49(8):1149-59
references.pmid: 16095636
references.citation: J Cereb Blood Flow Metab. 2007 Apr;27(4):697-709
references.pmid: 16850029
references.citation: J Neurosci. 2007 Oct 31;27(44):11869-76
references.pmid: 17978027
references.citation: Acta Neuropathol. 2007 Nov;114(5):459-69
references.pmid: 17687559
references.citation: Acta Neurochir Suppl. 2000;76:125-9
references.pmid: 11449990
references.citation: Intensive Care Med. 2008 Aug;34(8):1384-92
references.pmid: 18350273
references.citation: Brain Res. 2004 Aug 13;1017(1-2):85-91
references.pmid: 15261103
references.citation: Arch Gen Psychiatry. 2004 Jan;61(1):42-50
references.pmid: 14706943
references.citation: J Neurotrauma. 1993 Fall;10(3):263-71; discussion 273
references.pmid: 8258839
references.citation: Neurotherapeutics. 2010 Jan;7(1):43-50
references.pmid: 20129496
references.citation: Neuroscience. 2013 Nov 12;252:489-500
references.pmid: 23912033
references.citation: Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001048
references.pmid: 19160187
references.citation: J Neurotrauma. 2007;24 Suppl 1:S1-106
references.pmid: 17511534
references.citation: Libyan J Med. 2009 Sep 01;4(3):97-103
references.pmid: 21483522
references.citation: J Spec Oper Med. 2009 Summer;9(3):22-5
references.pmid: 19739473
references.citation: Transl Stroke Res. 2011 Dec;2(4):492-516
references.pmid: 22299022